Cargando…
Can CD200R1 Agonists Slow the Progression of Osteoarthritis Secondary to Injury?
Post-traumatic knee osteoarthritis is characterized by cartilage degeneration, subchondral bone remodeling, osteophyte formation, and synovial changes. Therapeutic targeting of inflammatory activity in the knee immediately post injury may alter the course of osteoarthritis development. This study ai...
Autores principales: | Vachhani, Kathak, Prodeus, Aaron, Nakamura, Sayaka, Rockel, Jason S., Hopfgartner, Adam, Kapoor, Mohit, Gariépy, Jean, Whyne, Cari, Nam, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964055/ https://www.ncbi.nlm.nih.gov/pubmed/35359946 http://dx.doi.org/10.3389/fimmu.2022.836837 |
Ejemplares similares
-
Perceptions of using lithium in fracture management: a survey of orthopaedic surgeons, fracture patients and the general public
por: Vachhani, Kathak, et al.
Publicado: (2019) -
Lithium for Fracture Treatment (LiFT): a double-blind randomised control trial protocol
por: Nam, Diane, et al.
Publicado: (2020) -
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
por: Prodeus, Aaron, et al.
Publicado: (2014) -
Probiotics: Can it modulate fracture healing?
por: Wang, Yufa, et al.
Publicado: (2023) -
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
por: Prodeus, Aaron, et al.
Publicado: (2018)